Rank | Gene Set | Z-score |
---|---|---|
1 | skeletal muscle adaptation (GO:0043501) | 9.66165980 |
2 | skeletal muscle fiber development (GO:0048741) | 8.64273935 |
3 | plasma membrane repair (GO:0001778) | 7.97643781 |
4 | * actin filament-based movement (GO:0030048) | 7.97430403 |
5 | myotube cell development (GO:0014904) | 7.38145882 |
6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.60238191 |
7 | skeletal muscle tissue regeneration (GO:0043403) | 6.59076291 |
8 | sarcomere organization (GO:0045214) | 6.47356003 |
9 | * striated muscle contraction (GO:0006941) | 6.45577712 |
10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.29396368 |
11 | creatine metabolic process (GO:0006600) | 6.26273403 |
12 | glycogen catabolic process (GO:0005980) | 6.22593682 |
13 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.06428332 |
14 | cytidine metabolic process (GO:0046087) | 5.89675395 |
15 | cytidine catabolic process (GO:0006216) | 5.89675395 |
16 | cytidine deamination (GO:0009972) | 5.89675395 |
17 | glucan catabolic process (GO:0009251) | 5.82777660 |
18 | myofibril assembly (GO:0030239) | 5.80123700 |
19 | striated muscle atrophy (GO:0014891) | 5.71390200 |
20 | * muscle contraction (GO:0006936) | 5.62446559 |
21 | purine nucleotide salvage (GO:0032261) | 5.59796255 |
22 | response to muscle activity (GO:0014850) | 5.52302129 |
23 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.51953220 |
24 | response to inactivity (GO:0014854) | 5.48468314 |
25 | carnitine shuttle (GO:0006853) | 5.44160164 |
26 | cellular polysaccharide catabolic process (GO:0044247) | 5.41526340 |
27 | regulation of cell communication by electrical coupling (GO:0010649) | 5.40249755 |
28 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.32285542 |
29 | polysaccharide catabolic process (GO:0000272) | 5.25915215 |
30 | muscle fiber development (GO:0048747) | 5.14398297 |
31 | striated muscle adaptation (GO:0014888) | 5.08121608 |
32 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.04787389 |
33 | * muscle system process (GO:0003012) | 4.99058146 |
34 | glucan biosynthetic process (GO:0009250) | 4.95398578 |
35 | glycogen biosynthetic process (GO:0005978) | 4.95398578 |
36 | muscle atrophy (GO:0014889) | 4.94064955 |
37 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.89353476 |
38 | IMP metabolic process (GO:0046040) | 4.66433716 |
39 | actomyosin structure organization (GO:0031032) | 4.63136339 |
40 | fatty acid transmembrane transport (GO:1902001) | 4.61616457 |
41 | NADH metabolic process (GO:0006734) | 4.54516033 |
42 | regulation of actin filament-based movement (GO:1903115) | 4.45461834 |
43 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.41960993 |
44 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.39126888 |
45 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.37711622 |
46 | cardiac muscle hypertrophy (GO:0003300) | 4.33439493 |
47 | glycogen metabolic process (GO:0005977) | 4.27124561 |
48 | negative regulation of muscle hypertrophy (GO:0014741) | 4.20589721 |
49 | glucan metabolic process (GO:0044042) | 4.18528074 |
50 | cellular glucan metabolic process (GO:0006073) | 4.18528074 |
51 | striated muscle hypertrophy (GO:0014897) | 4.13401199 |
52 | regulation of relaxation of muscle (GO:1901077) | 4.12082938 |
53 | muscle adaptation (GO:0043500) | 4.10776475 |
54 | muscle cell cellular homeostasis (GO:0046716) | 4.08071742 |
55 | muscle organ development (GO:0007517) | 4.03654472 |
56 | carnitine transmembrane transport (GO:1902603) | 4.03269859 |
57 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.01550500 |
58 | fructose metabolic process (GO:0006000) | 3.99387627 |
59 | muscle structure development (GO:0061061) | 3.97825566 |
60 | muscle organ morphogenesis (GO:0048644) | 3.88870332 |
61 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.86551454 |
62 | cardiac muscle contraction (GO:0060048) | 3.83868857 |
63 | response to activity (GO:0014823) | 3.83551022 |
64 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.82708238 |
65 | striated muscle cell development (GO:0055002) | 3.81500695 |
66 | myotube differentiation (GO:0014902) | 3.81182384 |
67 | skeletal muscle tissue development (GO:0007519) | 3.79032613 |
68 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.78359518 |
69 | positive regulation of myotube differentiation (GO:0010831) | 3.77523252 |
70 | muscle tissue morphogenesis (GO:0060415) | 3.75001728 |
71 | gluconeogenesis (GO:0006094) | 3.72824777 |
72 | muscle hypertrophy (GO:0014896) | 3.72247305 |
73 | neuronal action potential propagation (GO:0019227) | 3.69597702 |
74 | myoblast fusion (GO:0007520) | 3.69216166 |
75 | carnitine transport (GO:0015879) | 3.67505458 |
76 | amino-acid betaine transport (GO:0015838) | 3.67505458 |
77 | 2-oxoglutarate metabolic process (GO:0006103) | 3.66771067 |
78 | neuromuscular synaptic transmission (GO:0007274) | 3.65542590 |
79 | regulation of cofactor metabolic process (GO:0051193) | 3.61633709 |
80 | regulation of coenzyme metabolic process (GO:0051196) | 3.61633709 |
81 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.60573893 |
82 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.60573893 |
83 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.59876531 |
84 | negative regulation of protein localization to cell surface (GO:2000009) | 3.59471356 |
85 | striated muscle tissue development (GO:0014706) | 3.58894387 |
86 | IMP biosynthetic process (GO:0006188) | 3.50812051 |
87 | cardiac muscle cell development (GO:0055013) | 3.49977940 |
88 | cellular response to dexamethasone stimulus (GO:0071549) | 3.47579557 |
89 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.47144332 |
90 | negative regulation of muscle contraction (GO:0045932) | 3.43129090 |
91 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.42879591 |
92 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.42879591 |
93 | cellular carbohydrate catabolic process (GO:0044275) | 3.38883495 |
94 | adult heart development (GO:0007512) | 3.36449589 |
95 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.36124657 |
96 | regulation of sarcomere organization (GO:0060297) | 3.34877578 |
97 | syncytium formation (GO:0006949) | 3.34082128 |
98 | hexose biosynthetic process (GO:0019319) | 3.32446989 |
99 | regulation of myotube differentiation (GO:0010830) | 3.32168699 |
100 | tricarboxylic acid cycle (GO:0006099) | 3.31076973 |
101 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.31076271 |
102 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.28817929 |
103 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.27827324 |
104 | regulation of striated muscle contraction (GO:0006942) | 3.27450916 |
105 | muscle cell development (GO:0055001) | 3.26114233 |
106 | cardiac cell development (GO:0055006) | 3.24450096 |
107 | response to dexamethasone (GO:0071548) | 3.23430689 |
108 | regulation of skeletal muscle fiber development (GO:0048742) | 3.19316594 |
109 | positive regulation of myoblast differentiation (GO:0045663) | 3.18961075 |
110 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.18887485 |
111 | muscle hypertrophy in response to stress (GO:0003299) | 3.18887485 |
112 | cardiac muscle adaptation (GO:0014887) | 3.18887485 |
113 | muscle cell fate commitment (GO:0042693) | 3.18531942 |
114 | regulation of myoblast differentiation (GO:0045661) | 3.14146558 |
115 | neuromuscular junction development (GO:0007528) | 3.12400110 |
116 | cardiac myofibril assembly (GO:0055003) | 3.08770757 |
117 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.02640652 |
118 | keratinization (GO:0031424) | 3.02029334 |
119 | cellular polysaccharide metabolic process (GO:0044264) | 3.00497721 |
120 | cellular polysaccharide biosynthetic process (GO:0033692) | 2.96866918 |
121 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.96073062 |
122 | regulation of sulfur metabolic process (GO:0042762) | 2.95724973 |
123 | * actin-myosin filament sliding (GO:0033275) | 13.1231024 |
124 | * muscle filament sliding (GO:0030049) | 13.1231024 |
125 | regulation of skeletal muscle contraction (GO:0014819) | 12.7521876 |
126 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.7164196 |
127 | * actin-mediated cell contraction (GO:0070252) | 10.7004021 |
128 | * skeletal muscle contraction (GO:0003009) | 10.6873364 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.85219199 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.50368433 |
3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.40806114 |
4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.34277467 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.34034651 |
6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.18470762 |
7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.11438164 |
8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.60993053 |
9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56523110 |
10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.36806666 |
11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.36055676 |
12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.36055676 |
13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.27210071 |
14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.17385603 |
15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.11103814 |
16 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.10502998 |
17 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.10296827 |
18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96413094 |
19 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90182828 |
20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84980183 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79166745 |
22 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.78316997 |
23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.77723654 |
24 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.72123990 |
25 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.69814573 |
26 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.63851920 |
27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61201456 |
28 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.59487975 |
29 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57554486 |
30 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.55617242 |
31 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.48160053 |
32 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.47301940 |
33 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.47067792 |
34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46698621 |
35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.46095062 |
36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44777927 |
37 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.43260923 |
38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39835734 |
39 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.37548457 |
40 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34858861 |
41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32995070 |
42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32710158 |
43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31459071 |
44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29225616 |
45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28838181 |
46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28309117 |
47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27870790 |
48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27728125 |
49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26950960 |
50 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.25696195 |
51 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.23860957 |
52 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23284864 |
53 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.23115903 |
54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22023794 |
55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20753046 |
56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20212046 |
57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18355480 |
58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16911621 |
59 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.16334894 |
60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14002765 |
61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13632389 |
62 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.11995549 |
63 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11426755 |
64 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11408856 |
65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10647839 |
66 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09859513 |
67 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.08639903 |
68 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07182678 |
69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06894333 |
70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06671845 |
71 | P68_20966046_ChIP-Seq_HELA_Human | 1.06567786 |
72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06436086 |
73 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06096608 |
74 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05988287 |
75 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04476267 |
76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04288729 |
77 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03791561 |
78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03452754 |
79 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.03320328 |
80 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03075924 |
81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02943682 |
82 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02644484 |
83 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.02538426 |
84 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02500152 |
85 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01770265 |
86 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.01652158 |
87 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.01205205 |
88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99799068 |
89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99468102 |
90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99331012 |
91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99291466 |
92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98838122 |
93 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97997084 |
94 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97920835 |
95 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97101666 |
96 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96345599 |
97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96215179 |
98 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96215179 |
99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96133160 |
100 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96005601 |
101 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95176646 |
102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95079747 |
103 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94541724 |
104 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.94136123 |
105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93034313 |
106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92850800 |
107 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92551379 |
108 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92542789 |
109 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92329742 |
110 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.90449286 |
111 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.89508587 |
112 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.89306520 |
113 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88900020 |
114 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88777460 |
115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88329915 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88133162 |
117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88124637 |
118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.87736585 |
119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86386971 |
120 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86021207 |
121 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85909976 |
122 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.83899969 |
123 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83738557 |
124 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.83352110 |
125 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.83284918 |
126 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82821987 |
127 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82456657 |
128 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81406688 |
129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80657960 |
130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78960911 |
131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78960911 |
132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78260644 |
133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75251927 |
134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.74682017 |
135 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.74079584 |
136 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.72211686 |
137 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.71028126 |
138 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.70483336 |
139 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.69721537 |
140 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.69375652 |
141 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.69375652 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004145_abnormal_muscle_electrophysio | 7.75362791 |
2 | MP0000749_muscle_degeneration | 6.49880626 |
3 | MP0003646_muscle_fatigue | 5.87127412 |
4 | MP0000751_myopathy | 5.80103084 |
5 | MP0000747_muscle_weakness | 4.65035322 |
6 | MP0002106_abnormal_muscle_physiology | 4.22826824 |
7 | MP0000759_abnormal_skeletal_muscle | 3.86131767 |
8 | MP0004036_abnormal_muscle_relaxation | 3.85853005 |
9 | MP0005369_muscle_phenotype | 3.55242900 |
10 | MP0002269_muscular_atrophy | 3.46980908 |
11 | MP0004087_abnormal_muscle_fiber | 3.44985663 |
12 | MP0002837_dystrophic_cardiac_calcinosis | 3.44757252 |
13 | MP0000750_abnormal_muscle_regeneration | 3.33941239 |
14 | MP0004130_abnormal_muscle_cell | 3.12850956 |
15 | MP0005620_abnormal_muscle_contractility | 3.09024181 |
16 | MP0000733_abnormal_muscle_development | 2.59319382 |
17 | MP0004233_abnormal_muscle_weight | 2.47012383 |
18 | MP0002108_abnormal_muscle_morphology | 2.17792372 |
19 | MP0002332_abnormal_exercise_endurance | 2.14355145 |
20 | MP0005275_abnormal_skin_tensile | 1.93616793 |
21 | MP0005330_cardiomyopathy | 1.89521286 |
22 | MP0004185_abnormal_adipocyte_glucose | 1.81096377 |
23 | MP0006036_abnormal_mitochondrial_physio | 1.73707269 |
24 | MP0004084_abnormal_cardiac_muscle | 1.60929167 |
25 | MP0004270_analgesia | 1.47566615 |
26 | MP0002971_abnormal_brown_adipose | 1.44837242 |
27 | MP0005666_abnormal_adipose_tissue | 1.42373108 |
28 | MP0003705_abnormal_hypodermis_morpholog | 1.28733456 |
29 | MP0002972_abnormal_cardiac_muscle | 1.26927726 |
30 | MP0004215_abnormal_myocardial_fiber | 1.25890391 |
31 | MP0004484_altered_response_of | 1.25246270 |
32 | MP0000013_abnormal_adipose_tissue | 1.24829640 |
33 | MP0003950_abnormal_plasma_membrane | 1.23355527 |
34 | MP0010630_abnormal_cardiac_muscle | 1.16860102 |
35 | MP0005375_adipose_tissue_phenotype | 1.10941216 |
36 | MP0002822_catalepsy | 1.10689599 |
37 | MP0002796_impaired_skin_barrier | 1.02571302 |
38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01343537 |
39 | MP0003806_abnormal_nucleotide_metabolis | 0.98051348 |
40 | MP0002234_abnormal_pharynx_morphology | 0.97283944 |
41 | MP0005266_abnormal_metabolism | 0.96515371 |
42 | MP0001661_extended_life_span | 0.96343932 |
43 | MP0004134_abnormal_chest_morphology | 0.92064029 |
44 | MP0000762_abnormal_tongue_morphology | 0.88072089 |
45 | MP0006035_abnormal_mitochondrial_morpho | 0.82285606 |
46 | MP0001544_abnormal_cardiovascular_syste | 0.80252269 |
47 | MP0005385_cardiovascular_system_phenoty | 0.80252269 |
48 | MP0009250_abnormal_appendicular_skeleto | 0.75329596 |
49 | MP0001299_abnormal_eye_distance/ | 0.74432265 |
50 | MP0005503_abnormal_tendon_morphology | 0.71499098 |
51 | MP0000579_abnormal_nail_morphology | 0.71377798 |
52 | MP0003828_pulmonary_edema | 0.71149694 |
53 | MP0000372_irregular_coat_pigmentation | 0.71041553 |
54 | MP0009780_abnormal_chondrocyte_physiolo | 0.70747002 |
55 | MP0008961_abnormal_basal_metabolism | 0.67160854 |
56 | MP0000003_abnormal_adipose_tissue | 0.67155580 |
57 | MP0003656_abnormal_erythrocyte_physiolo | 0.66587325 |
58 | MP0004147_increased_porphyrin_level | 0.63528145 |
59 | MP0010030_abnormal_orbit_morphology | 0.63175564 |
60 | MP0004085_abnormal_heartbeat | 0.62472690 |
61 | MP0008438_abnormal_cutaneous_collagen | 0.60586859 |
62 | MP0003137_abnormal_impulse_conducting | 0.60322597 |
63 | MP0003879_abnormal_hair_cell | 0.58684299 |
64 | MP0001243_abnormal_dermal_layer | 0.55186207 |
65 | MP0005334_abnormal_fat_pad | 0.54826129 |
66 | MP0005501_abnormal_skin_physiology | 0.52866160 |
67 | MP0002078_abnormal_glucose_homeostasis | 0.52501509 |
68 | MP0005670_abnormal_white_adipose | 0.52480351 |
69 | MP0000383_abnormal_hair_follicle | 0.51700799 |
70 | MP0004043_abnormal_pH_regulation | 0.51233388 |
71 | MP0000343_altered_response_to | 0.50952367 |
72 | MP0002896_abnormal_bone_mineralization | 0.49402488 |
73 | MP0003045_fibrosis | 0.48911811 |
74 | MP0000266_abnormal_heart_morphology | 0.48235066 |
75 | MP0002127_abnormal_cardiovascular_syste | 0.44995374 |
76 | MP0002060_abnormal_skin_morphology | 0.44814053 |
77 | MP0008775_abnormal_heart_ventricle | 0.44260581 |
78 | MP0005452_abnormal_adipose_tissue | 0.44029925 |
79 | MP0008569_lethality_at_weaning | 0.43408031 |
80 | MP0009672_abnormal_birth_weight | 0.42578664 |
81 | MP0002089_abnormal_postnatal_growth/wei | 0.41594878 |
82 | MP0001346_abnormal_lacrimal_gland | 0.41263551 |
83 | MP0002734_abnormal_mechanical_nocicepti | 0.41201376 |
84 | MP0003959_abnormal_lean_body | 0.38787566 |
85 | MP0001849_ear_inflammation | 0.38301477 |
86 | MP0002114_abnormal_axial_skeleton | 0.37791869 |
87 | MP0002128_abnormal_blood_circulation | 0.36803767 |
88 | MP0006138_congestive_heart_failure | 0.36658964 |
89 | MP0000427_abnormal_hair_cycle | 0.35907543 |
90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.35726664 |
91 | MP0002249_abnormal_larynx_morphology | 0.35660922 |
92 | MP0005083_abnormal_biliary_tract | 0.34758353 |
93 | MP0005167_abnormal_blood-brain_barrier | 0.34047193 |
94 | MP0002638_abnormal_pupillary_reflex | 0.33473738 |
95 | MP0010678_abnormal_skin_adnexa | 0.32532840 |
96 | MP0005376_homeostasis/metabolism_phenot | 0.32212104 |
97 | MP0009115_abnormal_fat_cell | 0.30843417 |
98 | MP0005535_abnormal_body_temperature | 0.30342313 |
99 | MP0003948_abnormal_gas_homeostasis | 0.30300420 |
100 | MP0005319_abnormal_enzyme/_coenzyme | 0.29711915 |
101 | MP0000377_abnormal_hair_follicle | 0.29620699 |
102 | MP0004510_myositis | 0.29563749 |
103 | MP0005451_abnormal_body_composition | 0.27613266 |
104 | MP0006276_abnormal_autonomic_nervous | 0.26314573 |
105 | MP0005165_increased_susceptibility_to | 0.26010073 |
106 | MP0009931_abnormal_skin_appearance | 0.24620408 |
107 | MP0010771_integument_phenotype | 0.24079307 |
108 | MP0005423_abnormal_somatic_nervous | 0.23777040 |
109 | MP0000467_abnormal_esophagus_morphology | 0.23710382 |
110 | MP0001943_abnormal_respiration | 0.22899610 |
111 | MP0003385_abnormal_body_wall | 0.22455452 |
112 | MP0004142_abnormal_muscle_tone | 0.22264268 |
113 | MP0000647_abnormal_sebaceous_gland | 0.21948689 |
114 | MP0000230_abnormal_systemic_arterial | 0.21862351 |
115 | MP0005166_decreased_susceptibility_to | 0.21820237 |
116 | MP0003755_abnormal_palate_morphology | 0.21391852 |
117 | MP0010234_abnormal_vibrissa_follicle | 0.21023627 |
118 | MP0008770_decreased_survivor_rate | 0.20441108 |
119 | MP0005187_abnormal_penis_morphology | 0.20315688 |
120 | MP0002066_abnormal_motor_capabilities/c | 0.19464023 |
121 | MP0005332_abnormal_amino_acid | 0.18302093 |
122 | MP0004197_abnormal_fetal_growth/weight/ | 0.16037772 |
123 | MP0000534_abnormal_ureter_morphology | 0.14236004 |
124 | MP0004858_abnormal_nervous_system | 0.13859023 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.85599421 |
2 | Nemaline bodies (HP:0003798) | 9.46785882 |
3 | Exercise-induced myalgia (HP:0003738) | 8.22786461 |
4 | Distal arthrogryposis (HP:0005684) | 8.18007846 |
5 | Type 1 muscle fiber predominance (HP:0003803) | 7.92823974 |
6 | Exercise-induced muscle cramps (HP:0003710) | 7.37705209 |
7 | Myopathic facies (HP:0002058) | 6.89212812 |
8 | Round ear (HP:0100830) | 6.67863842 |
9 | Ulnar deviation of the wrist (HP:0003049) | 6.53558467 |
10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.33072966 |
11 | Calf muscle hypertrophy (HP:0008981) | 5.69835522 |
12 | Calcaneovalgus deformity (HP:0001848) | 5.68155088 |
13 | Deformed tarsal bones (HP:0008119) | 5.36813587 |
14 | Difficulty running (HP:0009046) | 5.17112137 |
15 | Absent phalangeal crease (HP:0006109) | 5.16962673 |
16 | Muscle fiber splitting (HP:0003555) | 5.11277519 |
17 | Hyporeflexia of lower limbs (HP:0002600) | 4.80346810 |
18 | Myoglobinuria (HP:0002913) | 4.77334661 |
19 | EMG: myopathic abnormalities (HP:0003458) | 4.46863792 |
20 | Increased connective tissue (HP:0009025) | 4.40905375 |
21 | Muscle stiffness (HP:0003552) | 4.35076395 |
22 | Abnormal finger flexion creases (HP:0006143) | 4.32676626 |
23 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.02484490 |
24 | Rhabdomyolysis (HP:0003201) | 3.97853014 |
25 | Abnormality of the calf musculature (HP:0001430) | 3.97525843 |
26 | Myotonia (HP:0002486) | 3.83592450 |
27 | Neck muscle weakness (HP:0000467) | 3.69181870 |
28 | Malignant hyperthermia (HP:0002047) | 3.66131658 |
29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.53197920 |
30 | Abnormality of the calcaneus (HP:0008364) | 3.45517057 |
31 | Frequent falls (HP:0002359) | 3.43170981 |
32 | Rimmed vacuoles (HP:0003805) | 3.40281529 |
33 | Difficulty climbing stairs (HP:0003551) | 3.26358687 |
34 | Subaortic stenosis (HP:0001682) | 3.26150456 |
35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.26150456 |
36 | Popliteal pterygium (HP:0009756) | 3.11846847 |
37 | Areflexia of lower limbs (HP:0002522) | 3.04579211 |
38 | Slender build (HP:0001533) | 3.03061462 |
39 | Shoulder girdle muscle weakness (HP:0003547) | 3.01162931 |
40 | Pelvic girdle muscle weakness (HP:0003749) | 3.01090055 |
41 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.90726106 |
42 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.90726106 |
43 | Fatigable weakness (HP:0003473) | 2.76278097 |
44 | Abnormality of the neuromuscular junction (HP:0003398) | 2.76278097 |
45 | Hyperkalemia (HP:0002153) | 2.69627206 |
46 | Asymmetric septal hypertrophy (HP:0001670) | 2.62187296 |
47 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.57535374 |
48 | EMG: neuropathic changes (HP:0003445) | 2.55875900 |
49 | Distal lower limb muscle weakness (HP:0009053) | 2.54836636 |
50 | Bundle branch block (HP:0011710) | 2.54779541 |
51 | Sudden death (HP:0001699) | 2.52342542 |
52 | Bulbar palsy (HP:0001283) | 2.46873716 |
53 | Spinal rigidity (HP:0003306) | 2.41920505 |
54 | Fetal akinesia sequence (HP:0001989) | 2.40168645 |
55 | Metatarsus adductus (HP:0001840) | 2.38299671 |
56 | Paralysis (HP:0003470) | 2.37108897 |
57 | Generalized muscle weakness (HP:0003324) | 2.34859515 |
58 | Amniotic constriction ring (HP:0009775) | 2.32762163 |
59 | Abnormality of placental membranes (HP:0011409) | 2.32762163 |
60 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29171656 |
61 | Ulnar deviation of finger (HP:0009465) | 2.28828995 |
62 | Facial diplegia (HP:0001349) | 2.25938612 |
63 | Muscular dystrophy (HP:0003560) | 2.25485580 |
64 | Muscle fiber atrophy (HP:0100295) | 2.23300148 |
65 | Gowers sign (HP:0003391) | 2.21014962 |
66 | Scapular winging (HP:0003691) | 2.19662295 |
67 | Weak cry (HP:0001612) | 2.16309190 |
68 | Proximal amyotrophy (HP:0007126) | 2.13882385 |
69 | Limb-girdle muscle weakness (HP:0003325) | 2.10864549 |
70 | Nonprogressive disorder (HP:0003680) | 2.09431941 |
71 | Hypoplastic ischia (HP:0003175) | 2.09133521 |
72 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.07331635 |
73 | Muscle fiber inclusion bodies (HP:0100299) | 10.1844059 |
74 | Limb-girdle muscle atrophy (HP:0003797) | 1.99270942 |
75 | Distal lower limb amyotrophy (HP:0008944) | 1.96976732 |
76 | Waddling gait (HP:0002515) | 1.89117707 |
77 | Progressive muscle weakness (HP:0003323) | 1.87681273 |
78 | Tarsal synostosis (HP:0008368) | 1.86791463 |
79 | Hip contracture (HP:0003273) | 1.83362318 |
80 | Abnormality of the ischium (HP:0003174) | 1.82440819 |
81 | Achilles tendon contracture (HP:0001771) | 1.79155266 |
82 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.78995828 |
83 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.78536709 |
84 | Aplasia of the musculature (HP:0100854) | 1.77583829 |
85 | Abnormality of the foot musculature (HP:0001436) | 1.74935063 |
86 | Breech presentation (HP:0001623) | 1.72644045 |
87 | Synostosis involving bones of the feet (HP:0009140) | 1.67999143 |
88 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.67999143 |
89 | Limited hip movement (HP:0008800) | 1.66471150 |
90 | Heart block (HP:0012722) | 1.64596675 |
91 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.64232198 |
92 | Abnormality of the Achilles tendon (HP:0005109) | 1.62468800 |
93 | Adducted thumb (HP:0001181) | 1.61035978 |
94 | Easy fatigability (HP:0003388) | 1.60935418 |
95 | Exercise intolerance (HP:0003546) | 1.58740393 |
96 | Ventricular tachycardia (HP:0004756) | 1.57233930 |
97 | Abnormal atrioventricular conduction (HP:0005150) | 1.55663275 |
98 | Increased density of long bones (HP:0006392) | 1.54303171 |
99 | Long clavicles (HP:0000890) | 1.52258170 |
100 | Short palpebral fissure (HP:0012745) | 1.52007156 |
101 | Congenital hip dislocation (HP:0001374) | 1.51533066 |
102 | Cholelithiasis (HP:0001081) | 1.46661010 |
103 | Type 2 muscle fiber atrophy (HP:0003554) | 1.46105377 |
104 | Lower limb amyotrophy (HP:0007210) | 1.44570008 |
105 | Ragged-red muscle fibers (HP:0003200) | 1.41469361 |
106 | Mesomelia (HP:0003027) | 1.40396637 |
107 | Stridor (HP:0010307) | 1.39162371 |
108 | Foot dorsiflexor weakness (HP:0009027) | 1.38457531 |
109 | Webbed neck (HP:0000465) | 1.37893320 |
110 | Ventricular arrhythmia (HP:0004308) | 1.37557546 |
111 | Abnormality of potassium homeostasis (HP:0011042) | 1.37485308 |
112 | Thin ribs (HP:0000883) | 1.36629053 |
113 | Hyperuricemia (HP:0002149) | 1.35095201 |
114 | Increased purine levels (HP:0004368) | 1.35095201 |
115 | Dilated cardiomyopathy (HP:0001644) | 1.33963460 |
116 | Lipoatrophy (HP:0100578) | 1.33488267 |
117 | Fibular aplasia (HP:0002990) | 1.33347800 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 8.85003339 |
2 | TTN | 6.28289991 |
3 | PHKG1 | 5.28210764 |
4 | PHKG2 | 5.28210764 |
5 | PIK3CG | 4.38747610 |
6 | NME1 | 4.20747662 |
7 | MAP2K3 | 2.85944953 |
8 | NEK1 | 2.27813789 |
9 | TRIB3 | 2.17454119 |
10 | MAP3K7 | 2.07138653 |
11 | PINK1 | 1.96506510 |
12 | PDK3 | 1.82196910 |
13 | PDK4 | 1.82196910 |
14 | DMPK | 1.73806223 |
15 | MAPK12 | 1.59714743 |
16 | PIK3CA | 1.56019873 |
17 | MAP2K4 | 1.53188954 |
18 | MUSK | 1.48133876 |
19 | MAP2K6 | 1.40014967 |
20 | BCKDK | 1.36616463 |
21 | PDK2 | 1.20415363 |
22 | CCNB1 | 1.19595598 |
23 | MAPKAPK3 | 1.14826290 |
24 | MAP3K3 | 1.07493863 |
25 | MARK1 | 0.94644598 |
26 | MAP3K13 | 0.81942778 |
27 | NEK9 | 0.79192628 |
28 | PRKAA2 | 0.77977254 |
29 | PRKAA1 | 0.73614906 |
30 | TRPM7 | 0.69947773 |
31 | PKN2 | 0.69944796 |
32 | TAOK2 | 0.69102398 |
33 | ERBB3 | 0.66508801 |
34 | EPHB1 | 0.64540387 |
35 | TAOK1 | 0.64392046 |
36 | MAPK11 | 0.63471334 |
37 | SIK1 | 0.63154982 |
38 | AKT2 | 0.61505658 |
39 | MAP3K11 | 0.59677484 |
40 | RIPK1 | 0.58926111 |
41 | CAMK2G | 0.57890032 |
42 | STK24 | 0.57835780 |
43 | ZAK | 0.54264996 |
44 | LIMK1 | 0.52535072 |
45 | ILK | 0.52153837 |
46 | CAMK4 | 0.51575711 |
47 | ARAF | 0.45021007 |
48 | EEF2K | 0.43565420 |
49 | PTK6 | 0.43320348 |
50 | CAMK2A | 0.40931186 |
51 | CAMK1 | 0.36081441 |
52 | CAMK2B | 0.35932697 |
53 | ERN1 | 0.34951190 |
54 | KSR2 | 0.32757654 |
55 | SGK1 | 0.32735914 |
56 | CDK19 | 0.32553712 |
57 | MAP3K6 | 0.31738097 |
58 | MAPK13 | 0.31288027 |
59 | LATS1 | 0.30308694 |
60 | MAP3K1 | 0.29497473 |
61 | MAP2K1 | 0.28535805 |
62 | PRKG1 | 0.28315724 |
63 | MOS | 0.28268729 |
64 | MAP3K5 | 0.28208837 |
65 | RPS6KB1 | 0.27384735 |
66 | PRKACB | 0.25718155 |
67 | ROCK1 | 0.25196701 |
68 | SGK2 | 0.24879392 |
69 | MAP3K10 | 0.24050280 |
70 | TBK1 | 0.23324483 |
71 | RPS6KA3 | 0.22970799 |
72 | MAPK4 | 0.21571203 |
73 | PKN1 | 0.21246922 |
74 | LATS2 | 0.21167610 |
75 | MAP3K9 | 0.20311816 |
76 | MAPK7 | 0.19605293 |
77 | FER | 0.19126852 |
78 | MST1R | 0.18878126 |
79 | PDPK1 | 0.17585644 |
80 | TIE1 | 0.17573177 |
81 | PRKACA | 0.17527204 |
82 | MARK2 | 0.17441056 |
83 | DDR2 | 0.17321899 |
84 | LRRK2 | 0.17094731 |
85 | RAF1 | 0.16795491 |
86 | PRKD1 | 0.16736886 |
87 | TGFBR2 | 0.16026120 |
88 | DAPK2 | 0.15688965 |
89 | DYRK1B | 0.15446900 |
90 | PRPF4B | 0.12414115 |
91 | BRAF | 0.12338504 |
92 | PDK1 | 0.11613162 |
93 | CAMK1G | 0.11534887 |
94 | TYK2 | 0.11383951 |
95 | FGFR1 | 0.10791113 |
96 | PAK6 | 0.10656534 |
97 | BMX | 0.09990458 |
98 | ICK | 0.09442255 |
99 | RPS6KB2 | 0.09396554 |
100 | ROCK2 | 0.08530829 |
101 | INSRR | 0.08132607 |
102 | RPS6KL1 | 0.07155143 |
103 | RPS6KC1 | 0.07155143 |
104 | RPS6KA1 | 0.07095310 |
105 | MTOR | 0.06750791 |
106 | SGK494 | 0.06711383 |
107 | SGK223 | 0.06711383 |
108 | NLK | 0.06275448 |
109 | ZAP70 | 0.05851275 |
110 | PRKG2 | 0.04773777 |
111 | PDGFRA | 0.04665672 |
112 | GSK3A | 0.04569530 |
113 | RPS6KA6 | 0.03256527 |
114 | JAK2 | 0.03236907 |
115 | FGFR3 | 0.03101801 |
116 | MAPK10 | 0.02969017 |
117 | PRKACG | 0.02403931 |
118 | MAPK8 | 0.02338123 |
119 | CSNK1D | 0.02089012 |
120 | PAK1 | 0.01903860 |
121 | TNK2 | 0.01887644 |
122 | MARK3 | 0.01802600 |
123 | RET | 0.01693636 |
124 | SGK3 | 0.01556228 |
125 | CAMK2D | 0.01282923 |
126 | PTK2B | 0.01100064 |
127 | KSR1 | -0.0187560 |
128 | FGFR4 | -0.0172094 |
129 | STK11 | -0.0115577 |
130 | MAPKAPK2 | -0.0001282 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.31658770 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.05484896 |
3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.90541311 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.55713462 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.51965116 |
6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.15250692 |
7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.97937161 |
8 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.34323833 |
9 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.29332549 |
10 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.28286668 |
11 | Circadian rhythm_Homo sapiens_hsa04710 | 2.15363795 |
12 | Insulin resistance_Homo sapiens_hsa04931 | 2.12077191 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12051070 |
14 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.11741299 |
15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.07208178 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.95474257 |
17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.80534567 |
18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.77076080 |
19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.68381838 |
20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.65387499 |
21 | Tight junction_Homo sapiens_hsa04530 | 1.59395009 |
22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.51145661 |
23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49444463 |
24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.47928791 |
25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.45432814 |
26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44714543 |
27 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38823386 |
28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.37393160 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35471029 |
30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33028392 |
31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28292432 |
32 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.27996071 |
33 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.26269786 |
34 | Focal adhesion_Homo sapiens_hsa04510 | 1.24319179 |
35 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20046724 |
36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17153766 |
37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16289077 |
38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.15783576 |
39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09179051 |
40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06447518 |
41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04881961 |
42 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.00075751 |
43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.94916550 |
44 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.89920093 |
45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89263572 |
46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86910476 |
47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.86527777 |
48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82564795 |
49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79077091 |
50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75244884 |
51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74941282 |
52 | Renin secretion_Homo sapiens_hsa04924 | 0.74483745 |
53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.72058461 |
54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68943785 |
55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68722796 |
56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66287547 |
57 | Platelet activation_Homo sapiens_hsa04611 | 0.62295279 |
58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60683939 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58525976 |
60 | Amoebiasis_Homo sapiens_hsa05146 | 0.58133290 |
61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56830901 |
62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55996348 |
63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52556120 |
64 | Adherens junction_Homo sapiens_hsa04520 | 0.51836263 |
65 | Insulin secretion_Homo sapiens_hsa04911 | 0.50659787 |
66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48281936 |
67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44751442 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42407072 |
69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39833227 |
70 | Long-term depression_Homo sapiens_hsa04730 | 0.38927683 |
71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37481845 |
72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36212206 |
73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36037893 |
74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35185237 |
75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33658739 |
76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32240285 |
77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.31909043 |
78 | Phototransduction_Homo sapiens_hsa04744 | 0.29656810 |
79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29606148 |
80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29098731 |
81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28967610 |
82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28473197 |
83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27070202 |
84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25693110 |
85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25280848 |
86 | Salivary secretion_Homo sapiens_hsa04970 | 0.24726355 |
87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24591626 |
88 | Peroxisome_Homo sapiens_hsa04146 | 0.23989889 |
89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23011740 |
90 | Melanogenesis_Homo sapiens_hsa04916 | 0.21394226 |
91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.20969480 |
92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20952334 |
93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.20603696 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19959990 |
95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.19245622 |
96 | Lysine degradation_Homo sapiens_hsa00310 | 0.18894783 |
97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18501376 |
98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.17964524 |
99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17533544 |
100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15879997 |
101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.15130730 |
102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.14843242 |
103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14445339 |
104 | Bile secretion_Homo sapiens_hsa04976 | 0.13295827 |
105 | Purine metabolism_Homo sapiens_hsa00230 | 0.13075013 |
106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.12707721 |
107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.12370001 |
108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.12152560 |
109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.11034796 |
110 | Glioma_Homo sapiens_hsa05214 | 0.10484281 |
111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.10246940 |
112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.10239100 |
113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08833610 |
114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08757969 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.08679278 |
116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07852298 |
117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.07834219 |